Ironwood Pharmaceuticals Inc SEC filings IRWD

Ironwood Pharmaceuticals Inc has 1,003 filings in SEC EDGAR's recent list, going back to Nov 4, 2014. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Ironwood Pharmaceuticals Inc SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Nov 5, 2026 —
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Officer or director change
Oct 16, 2026 Oct 12, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 18, 2026 Jun 16, 2026
8-K Current report
Other events
Jun 15, 2026 Jun 15, 2026
8-K/A Amended current report
Officer or director change
May 21, 2026 May 8, 2026
8-K Current report
Officer or director change
May 13, 2026 May 8, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 16, 2026
8-K Current report
Other events
Mar 11, 2026 Mar 10, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 25, 2026 Feb 25, 2026
8-K Current report
Results of operations
Jan 2, 2026 Jan 2, 2026
8-K Current report
Material agreement, Other events
Dec 23, 2025 Dec 18, 2025
8-K Current report
Other events
Nov 26, 2025 Nov 25, 2025
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
8-K Current report
Officer or director change
Oct 10, 2025 Oct 7, 2025
8-K Current report
Other events
Sep 3, 2025 Aug 29, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Auditor change
Jul 10, 2025 Jul 3, 2025
8-K Current report
Shareholder vote results
Jun 12, 2025 Jun 10, 2025
8-K Current report
Listing notice
Jun 3, 2025 May 28, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Jun 10, 2025
8-K Current report
Results of operations
Apr 25, 2025 Apr 25, 2025
8-K Current report
Other events
Apr 14, 2025 Apr 14, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Listing notice, Regulation FD disclosure
Mar 27, 2025 Mar 21, 2025
NT 10-K Filing Mar 3, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
8-K Current report
Exit or restructuring costs, Officer or director change
Jan 29, 2025 Jan 17, 2025
8-K Current report
Officer or director change
Dec 5, 2024 Dec 2, 2024
8-K Current report
Officer or director change
Nov 12, 2024 Nov 6, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
8-K Current report
Material agreement, New debt, Other events
Sep 30, 2024 Sep 27, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Shareholder vote results
Jun 21, 2024 Jun 21, 2024
8-K Current report
Officer or director change, Other events
Jun 20, 2024 Jun 20, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 25, 2024 —
DEF 14A Proxy statement Apr 25, 2024 Jun 18, 2024
10-K Annual report Feb 16, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 15, 2024 Feb 15, 2024
8-K Current report
Results of operations
Jan 8, 2024 Jan 8, 2024
UPLOAD Letter from the SEC Dec 6, 2023 —
CORRESP Letter to the SEC Nov 30, 2023 —
UPLOAD Letter from the SEC Nov 15, 2023 —
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
S-8 Employee stock plan registration Nov 9, 2023 —
S-3ASR Automatic shelf registration Nov 9, 2023 —
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
8-K/A Amended current report Sep 11, 2023 Jun 29, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Acquisition or sale of assets, New debt, Other events
Jun 30, 2023 Jun 29, 2023
SC TO-T/A Filing Jun 29, 2023 —
SC TO-T/A Filing Jun 26, 2023 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 22, 2023 Jun 20, 2023
SC TO-T/A Filing Jun 20, 2023 —
SC TO-T/A Filing Jun 16, 2023 —
SC TO-T Filing May 31, 2023 —
SC TO-C Filing May 23, 2023 —
SC TO-C Filing May 22, 2023 —
SC TO-C Filing May 22, 2023 —
8-K Current report
Material agreement, New debt, Other events
May 22, 2023 May 21, 2023
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
ARS Annual report to shareholders Apr 27, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 27, 2023 —
DEF 14A Proxy statement Apr 27, 2023 —
8-K Current report
Officer or director change
Apr 11, 2023 Apr 10, 2023
10-K Annual report Feb 16, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 16, 2023 Feb 16, 2023
8-K Current report
Results of operations
Jan 9, 2023 Jan 9, 2023
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Shareholder vote results
Jun 3, 2022 Jun 1, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
DEFA14A Additional proxy material Apr 21, 2022 —
DEF 14A Proxy statement Apr 21, 2022 Jun 1, 2022
10-K Annual report Feb 18, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 17, 2022 Feb 17, 2022
8-K Current report
Results of operations
Jan 10, 2022 Jan 10, 2022
8-K Current report
Officer or director change
Dec 1, 2021 Dec 1, 2021
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
8-K Current report
Officer or director change
Jul 22, 2021 Jul 16, 2021
8-K/A Amended current report
Officer or director change
Jun 24, 2021 Jun 1, 2021
8-K Current report
Officer or director change
Jun 7, 2021 Jun 1, 2021
8-K Current report
Shareholder vote results
Jun 3, 2021 Jun 2, 2021
10-Q Quarterly report May 6, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 6, 2021 May 6, 2021
DEFA14A Additional proxy material Apr 22, 2021 —
DEF 14A Proxy statement Apr 22, 2021 Jun 2, 2021
8-K Current report
Officer or director change
Mar 30, 2021 Mar 26, 2021
8-K/A Amended current report
Officer or director change
Mar 15, 2021 Feb 4, 2021
10-K Annual report Feb 17, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 17, 2021 Feb 17, 2021
8-K Current report
Officer or director change
Feb 8, 2021 Feb 4, 2021
8-K Current report
Results of operations
Jan 11, 2021 Jan 11, 2021
8-K Current report
Officer or director change
Dec 16, 2020 Dec 14, 2020
8-K Current report
Officer or director change
Dec 3, 2020 Dec 1, 2020
S-3ASR Automatic shelf registration Nov 6, 2020 —
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations, Officer or director change
Nov 5, 2020 Nov 4, 2020
8-K Current report
Exit or restructuring costs
Sep 29, 2020 Sep 29, 2020
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 6, 2020 Aug 6, 2020
8-K Current report
Shareholder vote results
Jun 8, 2020 Jun 3, 2020
10-Q Quarterly report May 6, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 6, 2020 May 6, 2020
8-K Current report
Officer or director change
Apr 21, 2020 Apr 17, 2020
DEFA14A Additional proxy material Apr 21, 2020 —
DEF 14A Proxy statement Apr 21, 2020 Jun 3, 2020
8-K Current report
Regulation FD disclosure
Mar 16, 2020 Mar 14, 2020
10-K Annual report Feb 13, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 13, 2020 Feb 13, 2020
8-K Current report
Results of operations
Jan 13, 2020 Jan 13, 2020
10-Q Quarterly report Oct 31, 2019 Sep 30, 2019
8-K Current report
Results of operations
Oct 31, 2019 Oct 31, 2019
8-K Current report
Material agreement
Sep 18, 2019 Sep 16, 2019
8-K Current report
Agreement ended
Sep 16, 2019 Sep 16, 2019
8-K Current report
Material agreement, New debt, Unregistered share sale
Aug 14, 2019 Aug 14, 2019
8-K Current report
Material agreement, New debt, Unregistered share sale
Aug 13, 2019 Aug 7, 2019
8-K Current report
Material agreement, Regulation FD disclosure
Aug 1, 2019 Aug 1, 2019
10-Q Quarterly report Jul 30, 2019 Jun 30, 2019
8-K Current report
Results of operations
Jul 30, 2019 Jul 30, 2019
8-K Current report
Other events
Jul 22, 2019 Jul 22, 2019
8-K Current report
Officer or director change
Jul 10, 2019 Jul 8, 2019
8-K Current report
Material agreement, Agreement ended
Jun 13, 2019 Jun 11, 2019
S-8 Employee stock plan registration May 31, 2019 —
S-8 Employee stock plan registration May 31, 2019 —
8-K Current report
Change to shareholder rights, Officer or director change, Shareholder vote results
May 31, 2019 May 30, 2019
8-K Current report
Results of operations
May 14, 2019 May 14, 2019
8-K/A Amended current report
Officer or director change
May 3, 2019 Jun 12, 2018
10-Q Quarterly report May 2, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 2, 2019 May 2, 2019
DEF 14A Proxy statement Apr 26, 2019 May 30, 2019
CT ORDER Filing Apr 26, 2019 —
CT ORDER Filing Apr 26, 2019 —
PRE 14A Preliminary proxy statement Apr 12, 2019 May 30, 2019
8-K Current report
Material agreement
Apr 8, 2019 Apr 5, 2019
8-K Current report
Material agreement, Acquisition or sale of assets, Officer or director change, Regulation FD disclosure
Apr 4, 2019 Mar 30, 2019
8-K Current report
Other events
Apr 2, 2019 Apr 2, 2019
8-K/A Amended current report
Officer or director change
Mar 28, 2019 Jan 3, 2019
CT ORDER Filing Mar 19, 2019 —
8-K Current report
Other events
Mar 8, 2019 Mar 8, 2019
8-K Current report
Regulation FD disclosure
Feb 26, 2019 Feb 26, 2019
10-K Annual report Feb 25, 2019 Dec 31, 2018
8-K Current report
Results of operations, Exit or restructuring costs
Feb 13, 2019 Feb 7, 2019
8-K Current report
Officer or director change
Jan 24, 2019 Jan 20, 2019
8-K Current report
Results of operations, Regulation FD disclosure
Jan 7, 2019 Jan 7, 2019
8-K Current report
Officer or director change
Jan 4, 2019 Jan 3, 2019
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jan 3, 2019 Dec 31, 2018
8-A12B/A Filing Jan 3, 2019 —
10-Q Quarterly report Nov 6, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 6, 2018 Nov 6, 2018
S-8 Employee stock plan registration Aug 6, 2018 —
S-8 Employee stock plan registration Aug 6, 2018 —
10-Q Quarterly report Aug 6, 2018 Jun 30, 2018
8-K Current report
Agreement ended, Results of operations, Exit or restructuring costs, Impairment
Aug 6, 2018 Jul 31, 2018
8-K Current report
Exit or restructuring costs
Jun 27, 2018 Jun 27, 2018
8-K Current report
Officer or director change
Jun 12, 2018 Jun 12, 2018
8-K Current report
Shareholder vote results
Jun 1, 2018 May 31, 2018
DEFA14A Additional proxy material May 14, 2018 —
DEFA14A Additional proxy material May 14, 2018 —
PRRN14A Preliminary proxy statement amendment May 10, 2018 —
UPLOAD Letter from the SEC May 9, 2018 —
DEFA14A Additional proxy material May 9, 2018 —
DEFA14A Additional proxy material May 9, 2018 —
10-Q Quarterly report May 4, 2018 Mar 31, 2018
DEFA14A Additional proxy material May 2, 2018 —
DEFA14A Additional proxy material May 2, 2018 —
DEFA14A Additional proxy material May 2, 2018 —
CORRESP Letter to the SEC May 2, 2018 —
DEFC14A Filing May 2, 2018 —
DEFA14A Additional proxy material May 1, 2018 —
DEFA14A Additional proxy material May 1, 2018 —
PREN14A Preliminary proxy statement May 1, 2018 Apr 19, 2018
8-K Current report
Results of operations
May 1, 2018 May 1, 2018

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IRWD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boston, MA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1446847

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.